GATEWAY 2026
Threehorizons.
One company,
three doors.
Your bridge between the world and Japan's pharmaceutical & health industry.
5+
COUNTRIES
7+
PARTNERS
2023
FOUNDED
3
DOORS
Care Link
Specialty Pharma × Last Mile
Delivering directly to patients
Last-mile delivery of specialty pharmaceuticals from pharmacies to patient homes. End-to-end cold chain management, adherence monitoring, and PSP integration.
Global Bridge
Import × Export
A two-way bridge between Japan and the world
Japan market entry for overseas pharma and raw materials. Global expansion for Japanese OTC and supplements. Regulatory to logistics, end-to-end.
garden
Supplement Development
From idea to product
Supplement and health food planning to manufacturing. OEM/ODM, raw material sourcing, and branding support.
Latest Insights
Healthcare insights shared by CEO Masaya Yamamoto on NewsPicks
膵臓がん新薬とスペシャリティ医薬品のアクセス
A new RAS/KRAS-targeted drug extended median overall survival in pancreatic cancer from 6.7 to 13.2 months. A major step in a long 'undruggable' area — but approval, pricing, and patient access in Japan will now be the focus.
フライドポテトと糖尿病リスク ― 食べ方の問題
The issue isn't the potato but the way it's eaten as fries. A BMJ study found three servings of fries a week raised type-2 diabetes risk by 20%, while boiling, baking, or mashing showed no significant rise. For prevention, 'swapping' is more realistic than 'banning'.
精神疾患11億人 ― 医療を超えた社会課題
Mental illness now affects roughly 1.17 billion people worldwide — no longer an individual issue but a matter of social infrastructure. It calls for early detection and a system spanning access, continued care, and return-to-work support.